These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2093382)

  • 1. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy.
    Bricaud H; Brottier L; Barat JL; Combe C; Boussens B; Bonnet J
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():861-5. PubMed ID: 2093382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy.
    Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H
    Eur Heart J; 1990 Mar; 11(3):207-12. PubMed ID: 2318223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of trimetazidine in the long-term treatment of cardiomyopathies of ischemic origin].
    Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):179-82. PubMed ID: 2735733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.
    Momen A; Ali M; Karmakar PK; Ali MZ; Haque A; Khan MR; Khalil MI; Hossain MS; Huda RM; Goni MN
    Indian Heart J; 2016; 68(6):809-815. PubMed ID: 27931552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Tuunanen H; Engblom E; Naum A; Någren K; Scheinin M; Hesse B; Juhani Airaksinen KE; Nuutila P; Iozzo P; Ukkonen H; Opie LH; Knuuti J
    Circulation; 2008 Sep; 118(12):1250-8. PubMed ID: 18765391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.
    Di Napoli P; Taccardi AA; Barsotti A
    Heart; 2005 Feb; 91(2):161-5. PubMed ID: 15657223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A
    Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
    El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
    Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
    Lévy S
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators.
    Levy S
    Am J Cardiol; 1995 Aug; 76(6):12B-16B. PubMed ID: 7645522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy.
    Zhao P; Zhang J; Yin XG; Maharaj P; Narraindoo S; Cui LQ; Tang YS
    Life Sci; 2013 Mar; 92(11):633-8. PubMed ID: 22484413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of various trimetazidine formulations in chronic coronary syndrome].
    Nagy VL; Herold Z
    Orv Hetil; 2020 Apr; 161(16):611-622. PubMed ID: 32323965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.